Background {#Sec1}
==========

India harbors a rich repository of untapped medicinal plants, with plenty of associated knowledge that needs to be appropriately utilized. The vast degree of diversity present in the country is directly related to the highly divergent ecosystem and altitudinal variations \[[@CR1]\]. Proper scientific investigation of the unexplored natural resources and subsequent commercialization could bring benefits to the stakeholders and also could play a central role in the drug development programs.

Arunachal Pradesh (AR) is a natural habitat of 5000 flowering species including 550 species of orchid plants. Further, it is interesting to note that nearly 300 species of the total orchids are rare whereas, only 37 species are of medicinal importance \[[@CR2]\]. Medicinal orchids prefer tropical climate though, a few of them grow under extreme climatic conditions also. Considering serenity of the habitat of AR and traditional use of orchids by the locals, we selected three relatively unexplored plants including *Rhynchostylis retusa* (Rr)*, Tropidia curculioides* (Tc), and *Satyrium nepalense* (Sn) for the present investigation*. R. retusa* of the genus Rhynchostylis is widely distributed all over North-eastern Himalayas and specially linked with the people of Assam, commonly called 'Kopu Phool' in Assamese language. It is a symbol of fertility and merriment \[[@CR3]\]. The roots of *R. retusa* are used in folk medicine for rheumatism, asthma, tuberculosis, nervous twitchings, cramps, infantile epilepsy, vertigo, palpitation, kidney stone, and menstrual disorders \[[@CR4]\]. *T. curculioides* is an endangered plant commonly found in Sikkim and Arunachal Pradesh. The decoction of roots of *T. curculioides* is used for cold stage of malaria and diarrhoea \[[@CR5]\]. *S. nepalense* (Hathjadi), a long terrestrial herb (25-60 cm) is commonly found at 2400--5000 m height. The tubers of *S. nepalense* are consumed by the native people as food, tonic and aphrodisiac \[[@CR6]\]. The plant is reported to have beneficial effects in the symptom of diarrhoea, malaria and dysentery \[[@CR7]\]. Qualitative phytochemical analysis and antimicrobial screening had been conducted with the plant extracts of *R. retusa* \[[@CR8], [@CR9]\]. However, any literature related to phytochemical investigation and biological activities of *T. curculioides* was not available. The presence of quercetin, had been reported from the extracts of *S. nepalense* \[[@CR10]\]*.* The literature search report inspired us to investigate the medicinal property of the plants.

The folk medicines of this region are used quite extensively for a number of common ailments and communicable diseases \[[@CR11]\]. Isolated living environment and poor access to healthcare is a threat for survival of the ethnic population all over India. Especially, the management of highly prevalent communicable diseases for e.g., tuberculosis (TB), visceral leishmaniasis (VL) and malaria is a great concern. TB in humans is caused by *Mycobacterium tuberculosis,* a facultative intracellular microbe belonging to *M. tuberculosis* complex. Further, the alarming rise of multi-drug-resistant (MDR), extensively drug-resistant (XDR) and totally drug resistant (TDR) strains of *M. tuberculosis,* emphasizes the need of new leads based on traditional knowledge \[[@CR12]\]. Visceral leishmaniasis, also known as kala azar is a fatal vector-borne illness caused by *Leishmania donovani.* It is the second most dreaded parasitic disease after malaria, causing considerable morbidity and mortality. Interestingly, a number of plant extracts and plant derived compounds are reported to possess significant leishmanicidal activity \[[@CR13]\] however, very few have reached to the stage of clinical trials. Also, the dramatic increase of new and emerging MDR bacterial strains emphasizes the need of fresh investigation with those natural resources, which has not been examined yet.

Methods {#Sec2}
=======

Plant materials {#Sec3}
---------------

The plants were collected from the foothills of Tipi & Khellong, and Doimara and Sange district of Arunachal Pradesh. The details of geographical location, altitude and place of collection have been mentioned in Table [1](#Tab1){ref-type="table"}. The plants were authenticated by Dr. Ona Apang, State Forest Research Institute, Itanagar, Arunachal Pradesh. The voucher specimens of *R. retusa* (AUUP/AIB/2014/01), *T. curculoidies* (AUUP/AIB/2014/02) and *S. nepalense* (AUUP/AIB/2015/03) were preserved in the herbarium of Amity Institute of Biotechnology, Amity University, Noida.Table 1Orchid species collected from Arunachal pradesh (AR); their geographical location, medicinal use and conservation statusS.No.Name of species and voucher no.Place of collectionGeographical locationAltitude (m)Medicinal useConservation status1*Rhyncostylis retusa*\
AUUP/AIB/2014/01Doimara\
(AR)N 26^0^58′02.0″ &\
E 092^0^25′10.3″357Rheumatism, asthma, tuberculosis, nervous twitchings, cramps, infantile epilepsyVulnerable2*Tropidia curculioides*\
AUUP/AIB/2014/02Tippi\
(AR)N 27^0^0′14.9″ &\
E 092^0^36′44.2″339Malaria and diarrhoeaRare3*Satyrium nepalense*\
AUUP/AIB/2014/03Sange\
(AR)N 27^0^27′30.1″ &\
E 092^0^06′17.4″3072Malaria, dysentery and aphrodisiacEndemic

Chemicals and reagents {#Sec4}
----------------------

The solvents were purchased from Merck, India. Middlebrook 7H9 (Becton-Dickinson) supplemented with 0.1% casitone, 0.2% glycerol and 10% OADC (oleic acid, albumin, dextrose and catalase), Resazurin dye \[Resazurin sodium salt (Sigma®, USA)\], MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide\] Sigma-Aldrich, 96-well plate with lid (Becton Dickinson), Acrodisc Syringe filter (Pall Life Sciences) with 0.2 μm filters, \>95% pure rifampicin (RIF), amphotericin B and miltefosine standard (≥98%) (Sigma-Aldrich) were used to conduct the following biological experiments. Pre-coated silica gel 60 F~254~ plates were used for analytical TLC.

Extraction and fractionation {#Sec5}
----------------------------

The dried plant material of *R. retusa* and *T. curculioides* were divided into root, stem and leaves while, *S. nepalense* was divided into pseudobulb, stem and leaves, and flowers. Dry weight of each part was noted and was extracted with methanol: water (9:1, 1 L× 24 h) for three consecutive days followed by extraction of the residue with H~2~O (0.5 L) at room temperature. The concentrated MeOH extracts of *R. retusa* and *T. curculioides* were suspended in water and was fractionated into diethyl ether (Et~2~O), *n*-BuOH and residual aqueous fractions successively. As, the plant material of *S. nepalense* was available in larger amount (4.23 Kg) compared to the other plants, more elaborate fractionation was carried out with the MeOH extract to obtain four fractions including *n*-hexane (*n*-Hex), dicholoromethane (DCM) and ethyl acetate (EtOAc) and residual aqueous fractions.. The organic solvents were removed under reduced pressure, below 40 °C in a rotary evaporator. Subsequently, a portion of aqueous extracts were lyophilized and refrigerated at 4 °C. Thin Layer Chromatography (TLC) profile of the active fractions was evaluated at varying polarity of ethyl acetate and *n*-Hex on pre-coated TLC plates.

Phytochemical screening of extracts {#Sec6}
-----------------------------------

Phytochemical analysis for the presence of alkaloids, flavonoids, steroids, reducing sugars, cardiac glycosides, terpenoids, anthraquinones, tannins, phlobatanins and saponins were conducted with each fraction by using standard protocol \[[@CR14]\].

Colorimetric redox indictor assay (CRI assay) {#Sec7}
---------------------------------------------

The pan sensitive strain of *M. tuberculosis* H37Rv TMC-102 (sensitive to streptomycin, isoniazide, rifampicin, ethambutol and pyrazinamide) and another MDR clinical isolate (Tb-14,348/16), resistant to rifampicin and isoniazid, was obtained as gift from Dr. V.M. Katoch, National JALMA Institute of Leprosy and other Mycobacterial Diseases, Agra, India. Briefly, the bacterium at log phase of growth (approximately 12 days), was transferred to a sterile vial containing glass beads and 8 mL of sterile 0.85% saline solution. The bacterial suspension was disaggregated by agitation and was allowed to stand for 15 min at room temperature. Turbidity of the suspension was compared with 1 McFarland tube standard and was adjusted with 7H9 broth to obtain a bacterial concentration of 3 × 10^8^ CFU/mL. The working solution at 1:20 dilution of the suspension, in Middlebrook 7H9 broth was evaluated by Colorimetric Redox Indicator Assay (CRI assay) \[[@CR15]\]. The extracts were dissolved in DMSO and were diluted appropriately to obtain final sample concentrations in the range of 100--500 μg/mL. The bacterial suspension at a concentration of 1.5 × 10^8^cells/mL was added to each well where, media along with bacterial suspension was considered as growth control and 0.5% DMSO with media and bacterial suspension were used as DMSO control. Besides, the well known antimycobacterial agent rifampicin was used as positive control. Sterile water was added to all perimeter wells to avoid evaporation. The microplates were incubated for 5--7 days at 37 °C in an incubator followed by addition of 25 μL of resazurin (0.02% *w*/*v*) dye to each well. Then, the plates were re-incubated at 37 °C for 24 h for color development. The minimum inhibitory concentration (MIC) was defined as the lowest drug/extract concentration that prevented color change of resazurin reagent from blue to pink. Blue color is interpreted as no mycobacterial growth and pink color as growth occurrence \[[@CR16]\]. All the experiments were carried out in duplicate with three independent experiments.

Leishmanicidal assay {#Sec8}
--------------------

Pan sensitive strain of *L. donovani* (DD8) was obtained from Department of Laboratory Medicine (AIIMS), New Delhi, India. The culture was routinely maintained at 24 °C in M-199 (GIBCO®, USA) medium supplemented with penicillin (100 U/mL), streptomycin (100 μg/mL) (Invitrogen, USA) and 10% heat inactivated fetal calf serum (FCS; GIBCO®, USA).

Promastigotes at logarithmic phase were seeded (1 × 10^6^ cells/mL) in 96-well microtiter plate in the presence of different concentrations of samples and incubated at 24 °C for 48 h. Thereafter, 100 μl of MTT (5 mg/mL) solution was added to each plate and incubated for 4 h at 24 °C. Finally, 100 μl of DMSO was added in each well to dissolve the formazan produced, followed by 18 h of incubation. The absorbance was measured at 570 nm and DMSO (0.5%) was considered as control while, amphotericin B and miltefosine was used as reference. Each assay was performed in duplicate with three independent experiments \[[@CR17]\].

To produce intracellular amastigotes, J774G8 (5 × 10^5^cells/mL) macrophage cells were plated onto 13-mm coverslips in 24-well plates for 1 h at 37 °C in a CO~2~ incubator. Non adherent cells were removed and the cells were further incubated overnight. Adherent cells were infected with *L. donovani* promastigotes at a parasite: macrophage ratio of 10: 1 and further incubated for 1 h. Unbound promastigotes were removed by extensive washing with PBS (pH 7.2). The infected macrophages were incubated with various dilutions of samples and the mean percentage of viable amastigotes was calculated relative to control and the results were expressed as concentration inhibiting the parasitic growth. The leishmanicidal effect of each sample was expressed in IC~50~ values.

Cell cytotoxicity assay {#Sec9}
-----------------------

The cell cytotoxicity was assessed against J774G8 murine macrophage cells (1 × 10^6^ cells/mL) with different concentrations of active fractions in the range of 15.62--250 μg/mL. The cell viability was determined by MTT assay \[[@CR18]\] as well. The results were expressed as percentage reductions in cell viability, compared to untreated control wells. The cytotoxic concentration required to kill 50% of the cells (CC~50~) was calculated.

Antibacterial assay {#Sec10}
-------------------

Five MDR bacterial clinical isolates of *Staphylococcus aureus* (2413), *Enterococcus* sp. (2449), *Serratia sp*. (2442), *Acinetobacter* sp. (2457) and *Escherichia coli* (2461) were obtained with respective antibiotic resistance profiles from Dr. Kumardeep Dutta Choudhary, Department of Medical Oncology, Rajiv Gandhi Cancer Research Institute, Delhi, India. All bacterial strains were revived in nutrient broth to conduct antibacterial screening \[[@CR19]\]. Briefly, nutrient agar plates were inoculated with 0.1 mL of each organism (1 × 10^8^ CFU/mL) and were treated with 50 μL of samples. The plates were incubated at 37 °C for 24 h. The antimicrobial activity was expressed as the mean diameter of inhibition zones (mm) with standard deviation produced by the tested fractions. Tetracycline and gentamycin were used as positive controls for disc diffusion assay. Minimum inhibitory concentrations (MIC) values were determined for the most potent extract by tube dilution method \[[@CR20]\]. A series of two fold dilutions of each extract ranging from 1 mg/mL to 0.1 mg/mL were done in Muller Hilton broth and were inoculated with 0.1 mL of suspension of the test organism. The tubes were incubated at 37 °C for 24 h and checked for turbidity. Minimum inhibitory concentration was determined as highest dilution of the extract that showed no visible growth.

Result and discussion {#Sec11}
=====================

Solvent extraction and fractionation of the plants afforded 30 components, dry weight of which is demonstrated in Table [2](#Tab2){ref-type="table"}. The results of qualitative analysis for different classes of phytochemicals viz., alkaloids, flavonoids, steroids, reducing sugar, cardiac glycosides, terpenoids, anthraquinones, tannins, phlobatanins and saponins had been presented in Table [3](#Tab3){ref-type="table"}. The phytochemical analysis data provides an overview of the chemical classes and their relative proportion in a fraction. Further, this knowledge could serve as a background to select the isolation strategy of the active ingredients.Table 2Details of extraction and fractionation of medicinal orchids obtained from ARS.No.NamePart used for fractionationFraction/ExtractYield (g)1*Rhynchostylis retusa* (Rr)- 2.34 kgRoots (1.178 kg)diethyl ether fraction\
(RrR Et~2~O)18.52*n-*butanol fraction\
(RrR *n*-BuOH)12.77aqueous extract\
(RrR Aq ext)5.00Stem (0.354 kg)diethyl ether fraction (RrS Et~2~O)8.44*n*-butanol fraction\
(RrS *n*-BuOH)4.82aqueous extract\
(RrS Aq ext)11.80Leaves (0.726 kg)diethyl ether fraction (RrL Et~2~O)6.28*n*-butanol fraction\
(RrL *n*-BuOH)10.92aqueous extract\
(RrL Aq ext)7.012*Tropidia curculioides* (Tc) - 1.622 KgRoots (0.922 kg)diethyl ether fraction\
(TcR Et~2~O)5.18*n*-butanol fraction\
(TcR *n*-BuOH)16.46aqueous extract\
(TcR Aq ext)38.99Stem (0.302 kg)diethyl ether fraction\
(TcS Et~2~O)2.13*n*-butanol fraction\
(TcS *n*-BuOH)15.62aqueous extract\
(TcS Aq ext)4.19Leaves (0.310 kg)diethyl ether fraction\
(TcL Et~2~O)16.00*n*-butanol fraction\
(TcL *n*-BuOH)11.96aqueous extract\
(TcL Aq ext)1.653*Satyrium nepalense* (Sn)- 4.233 kgPseudobulb\
(0.874 kg)*n*-hexane fraction\
(SnP *n*-Hex)5.12dichloromethane fraction\
(SnP DCM)8.32ethyl acetate fraction\
(SnP EtOAc)2.18aqueous extract\
(SnP Aq ext)4.32Flower\
(0.501 kg)*n*-hexane fraction\
(SnF *n*-Hex)3.50dichloromethane fraction\
(SnF DCM)2.10ethyl acetate fraction\
(SnF EtOAc)3.42aqueous extract\
(SnF Aq ext)5.12Leaves and Stem\
(2.550 kg)*n*-hexane fraction\
(SnL *n*-Hex)4.30dichloromethane fraction\
(SnL DCM)6.02ethyl acetate fraction\
(SnL EtOAc)2.12aqueous extract\
(SnL Aq ext)6.30 Table 3Phytochemical screening of crude fractions and extracts of three medicinal orchids of ARS.NoNameAlkaloidsFlavanoidsSteroidsReducing sugarsCardiac glycosidesTerpenoidsAnthraquinonesTanninsPhlobataninsSaponins1RrR Et~2~O+−−−++−−++2RrR *n* -BuOH++−−−+−−+−3RrR Aq ext−−−−+−−−++4RrS Et~2~O+++++++−++5RrS *n* -BuOH+++−−+−−+−6RrS Aq ext+−−−−+−−+−7RrL Et~2~O+−−−−−−−+−8RrL *n* -BuOH+−−−−−−−++9RrL Aq ext+−−−−−−−+−10TcR Et~2~O+++−−+++++11TcR *n* -BuOH−−−+−+−−−−12TcR Aq ext−−−++−−−−+13TcS Et~2~O−++−−++−−−14TcS *n* -BuOH−−−+−−−−−−15TcS Aq ext−−−++−−−−−16TcL Et~2~O−+−−−−+++−17TcL *n* -BuOH−−−+−−−−−+18TcL Aq ext−−−++−−−−+19SnP *n* -Hex+−−−−+−+−+20SnP DCM−+−−−+−−−+21SnP EtOAc++−−−−++−+22SnP Aq ext−−+−+−−+−+23SnF *n* -Hex++−+++−+++24SnF DCM−+−+−+−+−+25SnF EtOAc+++−+−++−+26SnF Aq ext−−+−+−++−+27SnL *n* -Hex+−−+−+−+−+28SnL DCM−+−−−−−−−+29SnL EtOAc++−−+−−+−+30SnL Aq ext−−++++−+++"+" indicates presence, "-" indicates AbsenceFlavanoids, steriods, alkaloids and tannins were detected by NaOH-HCl test, Salkowski's reaction, dragondorff reaction and ferric chloride test respectivelyAdditional tests were carried out to check the presence of reducing sugar, cardiac glycosides, phlobatannins, anthraqinones, saponins and terpenoids (Rajesh et al., 2010)

The antimycobacterial activity was determined by colorimetric redox indicator assay and the results were expressed in MIC values (Table [4](#Tab4){ref-type="table"}). An analysis of the results showed that *n-*hexane fraction of the flower of *S. nepalense* (*n-*Hex SnF) exhibited most significant antimycobacterial activity against H37Rv and MDR strains with MIC of 15.7 and 42.5 μg/mL followed by Et~2~O of roots of *R. retusa* (Et~2~O RrR) with MIC of 62.5 and 125 μg/mL respectively*.* It is well documented that MIC \<100 μg/mL is considered as potent while, 100--625 μg/mL represent moderate \[[@CR21]\] antimycobacterial activity. Few more fractions including, Et~2~O fraction of RrS and TcR; EtOAc fraction of SnP and SnF; and *n*-hexane fraction of SnL exhibited moderate antimycobacterial activity (MIC 125 μg/mL) against H37Rv strain. Also, better performance demonstrated by non polar fractions might be involving the lipophilic constituents, which causes disturbance to the lipid portion of the plasma membrane, leading to a loss of permeability and leakage of intracellular materials \[[@CR22]\]. Though, in vitro biological activities, not necessarily be transposed to clinical trials, but in vitro experiments clarify the safety aspects of a sample, to determine whether a drug candidate possesses scientific merit for further investigation.Table 4Minimum inhibitory concentration (MIC in μg/mL) of the antimycobacterial activity of crude extracts/fractions of three orchids against H37Rv and MDR strainS.NoExtract/FractionMIC values against H37Rv (μg/mL)MDR Strain-Tb-14,348/16 (μg/mL)1RrR Et~2~O62.51252RrR *n*-BuOH2505003RrR Aq ext\>1000\>10004RrS Et~2~O1251255RrS *n*-BuOH\>1000\>10006RrS Aq ext5005007RrL Et~2~O5005008RrL *n*-BuOH\>1000\>10009RrL Aq ext\>1000\>100010TcR Et~2~O125104.1611TcR *n*-BuOH\>1000\>100012TcR Aq ext25025013TcS Et~2~O500\>100014TcS *n*-BuOH\>1000\>100015TcS Aq ext1000\>100016TcL Et~2~O375\>100017TcL *n*-BuOH\>1000\>100018TcL Aq ext500\>100019SnP *n*-Hex25050020SnP DCM50050021SnP EtOAc12525022SnP Aq ext\>1000\>100023SnF *n*-Hex15.762.524SnF DCM500\>100025SnF EtOAc12525026SnF Aq ext187.525027SnL *n*-Hex12525028SnL DCM50050029SnL EtOAc\>100050030SnL Aq ext\>1000500Rifampicin (positive control)0.081Experiments were carried out in triplicate and results are expressed as mean of three replicate experiments. All crude extracts or fractions were dissolved in 0.2% DMSO and distilled water. Anti-Tb drug (RIF) was prepared according to manufacturer's instructions. Concentration range for each tested extracts or fractions were 15.6--1000 μg/mL; tested concentration range for positive control drug (RIF) was 0.25--16 μg/mL

In the second phase, the fractions were evaluated against promastigotes and intracellular amastigotes of *L. donovani* (DD8). The most efficient screening strategy for leishmanicidal activity targets i) easily cultured insect-infective promastigote stage and ii) intracellular amastigotes stage of the parasite. Chemotherapy of VL has been under-mined by drug resistance, variable efficacy, toxicity, parenteral administration, and requirement for long courses of treatment. Though, a number of plant extracts and plant derived compounds have shown promising leishmanicidal activity \[[@CR23]\], but majority of them possesses high cytotoxicity to the normal cells. Only three fractions including, Et~2~O RrR, *n*-Hex of SnF and SnP demonstrated moderate leishmanicidal activity in the range of 50--100 μg/mL against promastigotes and 18--25 μg/mL against intracellular amastigotes (Table [5](#Tab5){ref-type="table"}). To determine cell cytotoxicity of the active fractions, J774G8 murine macrophages were treated with different concentrations of the fractions. After 48 h, the viability was checked by MTT assay which showed negligible cytotoxic effect against macrophages at a concentration of CC~50~ values (97.2 ± 1.2, 89.4 ± 4.7 and 100.7 ± 1.7 μg/mL), which was higher than the IC~50~ values (Table [6](#Tab6){ref-type="table"}). The cell cytotoxiciy results clearly demonstrated that the active fractions have least harmful effect on the normal cells however; the parasitic cells were affected drastically at those concentrations.Table 5In vitro leishmanicidal activity against promastigotes and intracellular amastigotes of *L. donovani*S.No.Extracts and fractionsIC~50~ ± SD(μg/ml) promastigotesIC~50~ ± SD (μg/ml) amastigotes1RrR Et~2~O56.04 ± 0.0218.42 ± 0.262RrR *n*-BuOH5001253RrR Aq ext100010004RrS Et~2~O5005005RrS *n*-BuOH10005006RrS Aq ext10005007RrL Et~2~O5002508RrL *n*-BuOH10005009RrL Aq ext30025010TcR Et~2~O25010011TcR *n*-BuOH1000100012TcR Aq ext50020013TcS Et~2~O\>100050014TcS *n*-BuOH100055015TcS Aq ext50050016TcL Et~2~O\>100050017TcL *n*-BuOH\>100050018TcL Aq ext\>1000\>100019SnP *n*-Hex76.32 ± 2.3023.80 ± 0.7320SnP DCM100050021SnP EtOAc50020022SnP Aq ext50050023SnF *n*-Hex65.64 ± 0.2222.16 ± 0.9924SnF DCM100025025SnF EtOAc50025026SnF Aq ext50050027SnL *n*-Hex50020028SnL DCM100050029SnL EtOAc\>100050030SnL Aq ext10001000Amphotericin B0.055 ± 0.50.25 ± 0.48Miltefosine8.11 ± 0.364.37 ± 0.51The effect of different plant fractions on promastigotes (Log phase; 1 × 10^6^ cells/mL) and intracellularamastigotes were evaluated by MTT based colorimetric assay, efficacy was expressed in IC~50~ valuesStandard deviation (SD) was calculated for IC~50~ \< 125 μg/mL against promastigotes and amastigotes Table 6Activity against promastigotes and intracellular amastigotes of *Leishmania donovani*, cytotoxicity in J774G8 macrophage cells of active fractionsPlant fractionsPromastigote IC~50~ (μg/mL)Amastigote\
IC~50~ (μg/mL)J774.G8\
CC~50~ (μg/mL)RrR Et~2~O56.04 ± 0.2018.42 ± 0.2697.2 ± 1.2SnP *n*-Hex76.32 ± 2.3023.80 ± 0.7389.4 ± 4.7SnF *n*-Hex65.64 ± 0.2222.16 ± 0.99100.7 ± 1.7Data is presented as the mean ± SD of three independent experiments*IC* ~*50*~ inhibitory concentration of 50% parasites, *CC* ~*50*~ cytotoxicity concentration of 50% cells

In commensurate with previous observations, the IC~50~ values of the active fractions were lower against amastigotes than promastigotes \[[@CR24]\]. In this connection it is worthy to mention that screening of plants by bioassay guided fractionation only provides primary knowledge, which could be processed further by isolating compounds and evaluating their biological activity individually.

The present study was further extended to assess the best predictor of antibacterial activity against two gram positive and three gram negative MDR clinical isolates. The zone of inhibition values \>10 mm was considered as active (Table [7](#Tab7){ref-type="table"}). Interestingly, *n*-hexane fraction of all three parts of Sn demonstrated good antibacterial activity against *S. aureus* while, *n*-BuOH RrL and Et~2~O TcR showed significant efficiency against *Enterococcus sp.* However, most of the fractions failed to exhibit any significant activity against *Serratia sp*. Moreover, *n*-Hex SnF and Et~2~O TcR exhibited good antibacterial activity against *S. aureus* and *E. coli* with MIC values of 62.5 μg/mL and 125 μg/mL respectively while, only one fraction RrR Et~2~O showed substantial activity against *Acinetobacter sp*. with MIC of 104.16 μg/mL (Table [8](#Tab8){ref-type="table"}). The results also revealed that aqueous extracts did not possess any antimicrobial activity against the tested strains. Similar observations were also reported from other plant species \[[@CR25]\]. The results showed the efficacy of the plants as traditional medicine. Moreover, the active fractions were evaluated on pre-coated TLC plates with increasing concentration of ethyl acetate: *n*-Hex at 1: 9; 3: 7; and 1:1 proportions to generate the chemical profile. Maximum resolution was achieved at 3:7 proportion for Rr Et~2~O and TcR Et~2~O fractions and at 1:9 proportion for SnF *n*-Hex and SnP *n*-Hex (Fig. [1](#Fig1){ref-type="fig"}) fractions. The active fractions showed the presence of a number of distinct spots, which could be useful as a chemical profile and also in isolation of compounds.Table 7Antibacterial activity of various extracts/fractions of orchids by agar-well diffusion methodGram positiveGram negativeS. NoExtracts/fractions*Staphylococcus aureus* (2413)*Enterococcus sp.* (2449)*Serratia sp.* (2442)*Acinetobacter sp.* (2457)*E. coli* (2461)1RrR Et~2~O7.33 ± 0.577.66 ± 0.96.33 ± 0.5713 ± 0.87 ± 0.812RrR *n*-BuOH6.3 ± 0.56.0 ± 16.66 ± 0.57.3 ± 0.56.66 ± 0.53RrR Aq ext6.0 ± 16.0 ± 16.0 ± 16.0 ± 16.0 ± 14RrS Et~2~O6.33 ± 0.47.66 ± 0.47.66 ± 0.46.66 ± 0.96.66 ± 0.45RrS *n*-BuOH6.66 ± 0.57.33 ± 0.56 ± 07.33 ± 0.57.0 ± 06RrS Aq extNI6.66 ± 0.56.33 ± 0.55.66 ± 0.58.0 ± 1.07RrL Et~2~O8 ± 0.88.33 ± 0.47 ± 08.33 ± 0.49.33 ± 0.48RrL *n*-BuOH6.66 ± 0.511.33 ± 0.57.33 ± 0.57.33 ± 0.58 ± 09RrL Aq extNI7.33 ± 0.56.0 ± 08.66 ± 0.57.0 ± 010TcR Et~2~O7.33 ± 0.5712.66 ± 0.57NI7.66 ± 0.5712.66 ± 0.5711TcR *n*-BuOH7.66 ± 0.578.33 ± 0.57NI9.00 ± 0.008.33 ± 0.5712TcR Aq ext8.33 ± 0.577.00 ± 0.00NI7.33 ± 0.577.00 ± 0.0013TcS Et~2~O7.66 ± 0.577.66 ± 0.57NI7.33 ± 0.578.33 ± 0.5714TcS *n*-BuOH7.00 ± 0.008.33 ± 0.57NI8.00 ± 0.008.33 ± 0.5715TcS Aq ext7.33 ± 0.577.33 ± 0.57NI7.00 ± 0.007.33 ± 0.5716TcL Et~2~O7.00 ± 0.007.66 ± 0.57NI7.00 ± 0.007.33 ± 0.5717TcL *n*-BuOH8.33 ± 0.578.33 ± 0.57NI7.00 ± 0.007.00 ± 0.0018TcL Aq ext7.00 ± 0.007.33 ± 0.57NI7.00 ± 0.007.00 ± 0.0019SnP *n*-Hex12.23 ± 0.577.00 ± 0.00NI7.66 ± 0.579.85 ± 0.5720SnP DCM7.66 ± 0.577.00 ± 0.00NI7.33 ± 0.578.33 ± 0.5721SnP EtOAc7.00 ± 0.007.00 ± 0.00NI7.00 ± 0.007.33 ± 0.5722SnP Aq ext7.66 ± 0.577.00 ± 0.00NI9.00 ± 0.008.33 ± 0.5723SnF *n*-Hex12.00 ± 0.007.00 ± 0.00NI8.00 ± 0.0011.33 ± 0.5724SnF DCM8.33 ± 0.577.00 ± 0.00NI7.00 ± 0.007.00 ± 0.0025SnF EtOAc8.33 ± 0.577.00 ± 0.00NI7.33 ± 0.577.00 ± 0.0026SnF Aq ext7.33 ± 0.577.00 ± 0.00NI7.00 ± 0.007.33 ± 0.5727SnL *n*-Hex11.00 ± 0.007.00 ± 0.00NI7.00 ± 0.009.00 ± 0.0028SnL DCM9.00 ± 0.007.00 ± 0.009.00 ± 0.008.33 ± 0.577.66 ± 0.5729SnL EtOAc8.00 ± 0.007.00 ± 0.008.33 ± 0.577.66 ± 0.577.33 ± 0.5730SnL Aq ext7.33 ± 0.577.00 ± 0.00NININITetracycline16.56 ± 0.5815.71 ± 0.5817.42 ± 0.5815.71 ± 0.5818.85 ± 0.58Gentamycin15.76 ± 0.5815.71 ± 0.5811.56 ± 0.5814.56 ± 0.5818.79 ± 0.58Antibacterial activity expressed as diameter of zone of inhibition in mm including 6 mm as diameter of the wellValues represented as mean ± SD of three replicatesAll compounds were tested at concentration of 1 mg/mL30 μg Tetracycline and gentamycin discs were used as positive controlNI = no inhibition Table 8Minimum Inhibitory Concentration (MIC^a^ in μg/mL) of the most potent fractions from three orchidsGram positiveGram negativeS. NoExtracts/fractions*Staphylococcus aureus* (2413)*Enterococcus sp.* (2449)*Acinetobacter sp.* (2457)*E. Coli* (2461)1RrR Et~2~O250\>500104.162502RrL *n*-BuOH\>500250\>10005003TcR Et~2~O5002505001254SnP *n*-Hex166.6500\>1000\>10005SnF *n*-Hex125500500208.336SnL *n*-Hex250\>500\>1000\>500Tetracyclin0.5163.71.9^a^MIC determined by microdilution method and expressed in μg/mL Fig. 1Thin Layer Chromatography (pre-coated silica TLC plates) profile of bioactive fractions: **a** diethyl ether fraction of Rr Roots; **b** *n* **-**Hex fraction of Sn Flower; **c** *n* **-**Hex fraction of Sn Pseudobulb and (**d**) diethyl ether fraction of Tc Roots The TLC plates were developed in solvent system of varying polarity, i.e. ethyl acetate: *n*-Hexane (1:9, 3:7 and 1:1), \[EH\]. The plates were observed under UV light (254 nm)

Conclusion {#Sec12}
==========

The present study involving antimycobacterial, leishmanicidal and antibacterial activity of three orchids demonstrated *S. nepalense* as the most promising plant followed by *R. retusa* and *T. curculioides*. More specifically, the overall screening results identified *n*-Hex SnF as the most potent fraction possessing significantly high activities. Also, the fractions exhibited cell cytotoxicity well within the permissible limit. As proper phytochemical investigation of the plants has not been conducted so far, isolation and characterization of compounds could lead potential drug candidates for the experimental diseases in future.

Aq

:   Aqueous

AR

:   Arunachal Pradesh

CRI assay

:   Colorimetric redox indicator assay

DCM

:   Dichloromethane

DMSO

:   Dimethyl sulphoxide

Et~2~O

:   Diethyl ether

EtOAc

:   Ethyl acetate

FCS

:   Fetal calf serum

IC~50~

:   Medium inhibitory concentration

MDR

:   Multi-drug resistant

MIC

:   Minimum inhibitory concentration

MTB

:   *Mycobacterium tuberculosis*

MTT

:   3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide

*n*-BuOH

:   *n*-Butanol

*n*-Hex

:   *n*-Hexane

RIF

:   Rifampicin

Rr

:   *Rhynchostylis retusa*

Sn

:   *Satyrium nepalense*

TB

:   Tuberculosis

Tc

:   *Tropidia curculioides*

TDR

:   Total drug resistant

VL

:   visceral leishmaniasis

XDR

:   Extensively drug resistant
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